Multiple Sclerosis

Multiple sclerosis (MS) is a severe autoimmune disease of the central nervous system that affects the brain and spinal cord, causing problems with muscle movement, balance and vision.

Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurodegenerative disorder that damages the nerves in the brain and spinal cord, leading to problems with muscle movement, balance and vision.

Benign Multiple Sclerosis (MS)

Cognitive Impairment and Multiple Sclerosis

Optic Neuritis and Multiple Sclerosis

Multiple Sclerosis and Pregnancy

Epigenetics for Multiple Sclerosis

Types of Multiple Sclerosis (MS)

At-Home Physiotherapy Exercises for Multiple Sclerosis

Primary Progressive Multiple Sclerosis (PPMS)

Heat Intolerance in Multiple Sclerosis

See more featured articles »

Working Towards Earlier Diagnosis of Multiple Sclerosis

Remyelination Strategies for Multiple Sclerosis

Secondary Progressive Multiple Sclerosis (SPMS)

Multiple Sclerosis in Children

Multiple Sclerosis and Women’s Health

Multiple sclerosis and beta interferon

Early Signs of Multiple Sclerosis

What Causes Multiple Sclerosis?

Multiple Sclerosis Epidemiology

Relapsing-Remitting Multiple Sclerosis (RRMS)

Anti-Myelin Antibodies in Multiple Sclerosis

Multiple sclerosis and smoking

How is RRMS Different from PPMS and SPMS?

Latest Multiple Sclerosis News and Research

Wearable sensors as a tool for MS monitoring

Wearable sensors may help identify people with multiple sclerosis (MS) who are more likely to have worsening disability and loss of brain volume, according to a study published on March 4th, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

4 Mar 2026

Canadian wildfire pollution associated with increased stroke severity

Short-term surges in air pollution in New Jersey from the 2023 Canadian wildfires were associated with a higher stroke rate and more serious strokes, according to a preliminary study released March 3, 2026, that will be presented at the American Academy of Neurology's 78th Annual Meeting taking place April 18-22, 2026, in Chicago and online.

3 Mar 2026

UCF researcher explores insulin signaling as new target for diabetic neuropathy

Neuropathy – chronic pain, numbness and tingling in the hands and feet – is a challenging fact of life for many patients with Type 1 diabetes.

2 Mar 2026

Study finds association between groundwater age and Parkinson’s risk

People whose drinking water came from newer groundwater had a higher risk of developing Parkinson's disease than those whose drinking water came from older groundwater, according to a preliminary study released March 2, 2026, that will be presented at the American Academy of Neurology's 78th Annual Meeting taking place April 18-22, 2026, in Chicago and online.

2 Mar 2026

New research initiative aims to predict and prevent diseases before they start

What if doctors could tell you a disease was coming years before you felt a single symptom-and stop it in its tracks? That is the goal of a sweeping new research initiative launched by the Icahn School of Medicine at Mount Sinai in collaboration with the Uniformed Services University of the Health Sciences (USU) and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF).

2 Mar 2026

The surprising neurological benefits of GLP-1s

For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such as diabetes and weight loss, was associated with fewer emergency department visits and hospitalizations overall, and with less need for medications used to stop and prevent migraine attacks, according to a preliminary study released March 1, 2026, that will be presented at the American Academy of Neurology's 78th Annual Meeting taking place April 18-22, 2026, in Chicago and online.

2 Mar 2026

Tick-derived protein discovery can advance treatment for inflammatory diseases

When the immune system detects a harmful or foreign agent it triggers an inflammatory response small proteins called chemokines direct immune cells to the site of the injury or infection, resulting in the invader being inactivated.

27 Feb 2026

To avoid care disruptions, know when the clock runs out on your prior authorization

A woman with multiple sclerosis wanted to be able to walk up the stairs at home without losing her balance.

27 Feb 2026

Rising vitamin K shot refusal increases newborn brain injury risk

Increasing numbers of parents are refusing vitamin K shots for their newborns, putting infants at greater risk of avoidable brain injuries, according to a preliminary systematic review released February 26, 2026, that will be presented at the American Academy of Neurology's 78th Annual Meeting taking place April 18-22, 2026, in Chicago and online.

26 Feb 2026

Morning chronotype and exercise associated with reduced ALS risk

Being an early bird, also called a morning person, and being more physically active are associated with lower risks of amyotrophic lateral sclerosis (ALS), according to a preliminary study released February 25, 2026, that will be presented at the American Academy of Neurology's 78th Annual Meeting taking place April 18-22, 2026, in Chicago and online.

25 Feb 2026

Smoking status influences Parkinson's disease risk and mortality outcomes

A new study of smokers finds that currently smoking is associated with a lower risk of developing Parkinson's disease, but quitting smoking was associated with a lower risk of death.

25 Feb 2026

Study finds brain changes related to worse memory in football players with repetitive head impacts

In former college and professional football players, a new study has found higher levels of inflammation were associated with worse brain structure, which in turn was related to worse memory.

25 Feb 2026

New maps of mouse brains reveal patterns of myelin formation

Johns Hopkins scientists say they have used 3D imaging, special microscopes and artificial intelligence (AI) programs to construct new maps of mouse brains showing a precise location of more than 10 million cells called oligodendrocytes.

22 Feb 2026

Genome sequencing data reveals new insights into Epstein-Barr virus immunity

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown.

19 Feb 2026

Prenatal lead exposure linked to lower cognition six decades later

Exposure to lead before birth is associated with lower performance 60 years later on tests of thinking and memory skills in female participants, according to a study published on February 18, 2026, in Neurology, the medical journal of the American Academy of Neurology.

18 Feb 2026

Does Ginkgo biloba help dementia? New review examines the evidence

A major Cochrane review examines whether a widely used herbal supplement truly supports cognitive function, revealing modest dementia benefits but limited evidence for prevention or early impairment.

18 Feb 2026

Can GLP-1 drugs slow neurodegeneration? New review finds promising signals but limited clinical proof

This review examines how GLP-1 receptor agonists may influence neurodegenerative disease biology through metabolic, inflammatory, mitochondrial, and proteostasis pathways. Evidence from mechanistic, preclinical, and early clinical studies suggests potential neuroprotective effects, but definitive disease-modifying benefit remains unproven.

17 Feb 2026

Study reveals dynamic nature of myelin swellings

An international research team of Amsterdam UMC, VU LaserLab, the Netherlands Institute for Neuroscience and the University of Edinburgh have gained new insights into the dynamics of myelin swellings in the brain.

12 Feb 2026

Lifelong learning associated with lower risk of Alzheimer's disease

Engaging in a variety of intellectually stimulating activities throughout life, such as reading, writing and learning a language, is associated with a lower risk of Alzheimer's disease and slower cognitive decline, according to a new study published on February 11, 2026, in Neurology, the medical journal of the American Academy of Neurology.

11 Feb 2026

Traumatic brain injury linked to long-term work disability

Having a traumatic brain injury, no matter how serious, is associated with a greater likelihood of qualifying for work disability up to five years later, according to a study published February 11, 2026, in Neurology, the medical journal of the American Academy of Neurology.

11 Feb 2026